Pharma-Bio Serv (PBSV) Upgraded at ValuEngine

ValuEngine upgraded shares of Pharma-Bio Serv (OTCMKTS:PBSV) from a strong sell rating to a sell rating in a research report report published on Friday morning.

Pharma-Bio Serv (OTCMKTS PBSV) opened at $0.52 on Friday. Pharma-Bio Serv has a one year low of $0.32 and a one year high of $0.99.

COPYRIGHT VIOLATION NOTICE: “Pharma-Bio Serv (PBSV) Upgraded at ValuEngine” was reported by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://www.com-unik.info/2017/12/04/pharma-bio-serv-pbsv-upgraded-at-valuengine.html.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab).

To view ValuEngine’s full report, visit ValuEngine’s official website.

What are top analysts saying about Pharma-Bio Serv Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Pharma-Bio Serv Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit